Form SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1]:
SEC Accession No. 0001829126-25-001489
Filing Date
2025-03-05
Accepted
2025-03-05 16:59:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14F1 cyclacel_sc14f1.htm SC 14F1 139997
  Complete submission text file 0001829126-25-001489.txt   141917
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filed by) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1 | Act: 34 | File No.: 005-80136 | Film No.: 25712175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)